Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML.

ABSTRACT:

SUBMITTER: Murphy T 

PROVIDER: S-EPMC6693012 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature